| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
43,502 |
36,451 |
$2.33M |
| 99213 |
|
5,491 |
4,614 |
$238K |
| 99406 |
|
14,125 |
11,532 |
$81K |
| 99204 |
|
568 |
506 |
$53K |
| 96372 |
|
3,443 |
2,668 |
$37K |
| 99310 |
Prolong nursin fac eval 15m |
1,500 |
1,033 |
$26K |
| 36415 |
|
12,677 |
11,085 |
$18K |
| 96127 |
|
2,915 |
2,680 |
$18K |
| 90674 |
|
971 |
822 |
$16K |
| 99308 |
|
1,343 |
920 |
$11K |
| 99396 |
|
88 |
67 |
$6K |
| 1036F |
|
6,162 |
5,385 |
$5K |
| 90471 |
|
693 |
621 |
$4K |
| 99309 |
|
390 |
218 |
$3K |
| 4004F |
|
4,145 |
3,514 |
$3K |
| 99442 |
|
122 |
105 |
$2K |
| 90756 |
|
101 |
97 |
$1K |
| 1101F |
|
1,146 |
1,047 |
$1K |
| 87426 |
|
50 |
42 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
294 |
265 |
$806.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
623 |
529 |
$702.71 |
| 90661 |
|
88 |
82 |
$640.50 |
| 99441 |
|
44 |
38 |
$521.53 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,273 |
1,026 |
$478.87 |
| G0008 |
Administration of influenza virus vaccine |
307 |
242 |
$410.97 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
45 |
38 |
$369.23 |
| 1090F |
|
590 |
566 |
$300.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
334 |
271 |
$233.04 |
| 1125F |
|
215 |
199 |
$175.00 |
| 4040F |
|
154 |
126 |
$125.00 |
| 80061 |
|
109 |
81 |
$109.29 |
| 1170F |
|
843 |
736 |
$100.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
48 |
43 |
$82.81 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
18 |
12 |
$61.01 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
14,332 |
12,525 |
$4.88 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,246 |
1,176 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,081 |
951 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
325 |
252 |
$0.00 |
| G8400 |
Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given |
112 |
91 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
2,130 |
1,919 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,596 |
2,348 |
$0.00 |
| G9250 |
Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment |
2,506 |
2,228 |
$0.00 |
| G9916 |
Functional status performed once in the last 12 months |
598 |
571 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
38 |
26 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
3,274 |
2,838 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
699 |
667 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
40 |
31 |
$0.00 |
| 1100F |
|
54 |
49 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
20 |
12 |
$0.00 |
| G9665 |
Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy |
14 |
14 |
$0.00 |
| G9917 |
Documentation of advanced stage dementia and caregiver knowledge is limited |
17 |
12 |
$0.00 |
| 2028F |
|
26 |
20 |
$0.00 |
| M1069 |
Patient screened for future fall risk |
2,773 |
2,486 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
16,676 |
14,401 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
3,979 |
3,575 |
$0.00 |
| 3017F |
|
182 |
157 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
1,831 |
1,634 |
$0.00 |
| G2197 |
Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user |
1,268 |
1,204 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
428 |
378 |
$0.00 |
| 1111F |
|
597 |
447 |
$0.00 |
| G9793 |
Patient is currently on a daily aspirin or other antiplatelet |
364 |
341 |
$0.00 |
| G8973 |
Most recent hemoglobin (hgb) level < 10 g/dl |
58 |
52 |
$0.00 |
| G9251 |
Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment |
93 |
89 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
108 |
88 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
806 |
758 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
202 |
188 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
630 |
572 |
$0.00 |
| G9189 |
Beta-blocker therapy prescribed or currently being taken |
40 |
39 |
$0.00 |
| 1006F |
|
196 |
155 |
$0.00 |
| G9188 |
Beta-blocker therapy not prescribed, reason not given |
28 |
26 |
$0.00 |